PeerView Clinical Pharmacology CME/CNE/CPE Video

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

http://ww2.peerview.com

Eine durchschnittliche Folge dieses Podcasts dauert 52m. Bisher sind 1272 Folge(n) erschienen. Alle 2 Tage erscheint eine Folge dieses Podcasts.

Gesamtlänge aller Episoden: 45 days 17 hours 44 minutes

subscribe
share






David Weidman, MD - Therapeutic Advances in the Early Treatment of Alzheimer’s Disease: Expert Insights on Novel Biomarkers and Emerging Disease-Modifying Therapies


Go online to PeerView.com/YFY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 12, 2022  36m
 
 

Reynold A. Panettieri, Jr., MD - The Future of Severe Asthma Treatment Is Here: Expert Insights on the Rationale for Targeting Epithelial Alarmins


Go online to PeerView.com/NDA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 12, 2022  31m
 
 

Zev A. Wainberg, MD - Targeting TIGIT to Extend Immunotherapy Benefits to More Cancer Patients: A Strategy to Amplify Immune Response and Enhance or Restore Antitumor Activity


Go online to PeerView.com/EBJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 9, 2022  55m
 
 

Stuart S. Winter, MD - Adapting to Innovation in Pediatric ALL: Guidance on Optimizing Modern Therapy and the Role of Novel Asparaginase Compounds


Go online to PeerView.com/KQX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 9, 2022  58m
 
 

Jeanne M. Palmer, MD - The Modern Management of Myelofibrosis: Practical Perspectives Surrounding the Use of JAK Inhibitors and Novel Therapeutics in the Peri-Transplant Setting


Go online to PeerView.com/BJB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 9, 2022  1h3m
 
 

Nelson Chao, MD, MBA - Upgrading the VOD/SOS Management Tool Kit: Guidance for Effective Diagnostic Confirmation, Grading, and Treatment


Go online to PeerView.com/GBV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 9, 2022  51m
 
 

John N. Allan, MD - Reaping the Rewards of Innovative Care in CLL: From Targeted Strategies to Cellular Therapy


Go online to PeerView.com/GUR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 7, 2022  59m
 
 

James M. Foran, MD, FRCPC - Landmarks Across the Patient Journey in AML: Applying Evidence With Novel Therapeutics Pre- and Post-AlloHCT


Go online to PeerView.com/HJG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 7, 2022  53m
 
 

Amber C. King, PharmD, BCOP - Making Sense of New Standards for CLL: Pharmacist Insights on Targeted Therapy and the Delivery of Team-Based Care


Go online to PeerView.com/AFW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 7, 2022  20m
 
 

Kurt A. Schalper, MD, PhD - Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors


Go online to PeerView.com/EZK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 5, 2022  1h27m